Company intelligence

Altay Therapeutics

BiotechSan Carlos, California, USA

Recent changes

  1. Oct 20, 2026Raised $37M Series A Pulse 2.0
  2. Sep 17, 2026Raised $15.7M SEC EDGAR Form D

Funding History

2 events · sources dated per row
DateEventAmountValuationInvestorsSource
Oct 20, 2026Series A$37M—
Sound BioventuresHealthCapFountain Healthcare PartnersBiogen New Ventures+2 more
Pulse 2.0
Sep 17, 2026funding round$15.7M—
SEC EDGAR Form D
Funding timeline · 2 rounds · $53M tracked
$0.0M$21M$41M$16MRoundSep 26$37MSeries AOct 26
No Value Add Pulse story covers Altay Therapeutics yet. This profile is built from filings, registries and sourced research — every figure above carries its date and source.

Related Companies

Sources & methodologyshow
Where these figures come from

Figures are labelled Reported (a source states it), Estimated, Derived (computed from other facts) or Rumored (in talks / unconfirmed). Rumors never replace a confirmed figure. Each figure keeps its own as-of date; history is preserved rather than overwritten.

How we verify data ·